[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Emanuele Barabino\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100610658",false,"NCT07230444","Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization","Validation and Implementation With Artificial Intelligence of Software for the Intra-procedural Assessment of Uterine Artery EMBOlization","AI-EMBO","Inclusion Criteria:\n\n* Female patients ≥18 years\n* Symptomatic uterine fibroids (e.g., bleeding, bulk symptoms, pain)\n* Underwent UAE as definitive therapy\n* Availability of baseline clinical\u002Fimaging data (for retrospective arm) or ability to provide informed consent (for prospective arm)\n\nExclusion Criteria:\n\n* Lack of clinical follow-up\n* Poor quality or incomplete angiographic images.","FEMALE","18 Years","55 Years",{"count":20,"type":21},250,"ESTIMATED","6 Months","OBSERVATIONAL","Uterine artery embolization is a minimally invasive treatment for symptomatic uterine fibroids, but intra-procedural assessment of embolization adequacy currently relies on subjective angiographic criteria. This study evaluates a proprietary angiographic analysis software (AQ-VERO) that extracts quantitative time-to-density perfusion metrics in real time. The study aims to (1) validate the accuracy and reproducibility of AQ-VERO during uterine artery mebolization, and (2) develop an AI-based decision support system using AQ-VERO-derived metrics to improve objective intra-procedural assessment of treatment endpoints.",[26],"Uterine Fibroids (UF)",[28,29,30,31,32],"uterine fibroids","embolization","uterine artery embolization","quantitative imaging","artificial intelligence","NOT_YET_RECRUITING","2025-11-15",{"date":36,"type":37},"2025-11-19","ACTUAL",{"date":39,"type":21},"2025-12-01",{"date":41,"type":21},"2027-05-31",{"name":43,"class":44},"Emanuele Barabino","OTHER",""]